Skip to main content
HR 4178 116th Congress House

REFUND Act of 2019

Official title: To amend title XVIII of the Social Security Act to require manufacturers of certain single-dose vial drugs payable under part B of the Medicare program to prov… Show full official titleShow less

Official title: To amend title XVIII of the Social Security Act to require manufacturers of certain single-dose vial drugs payable under part B of the Medicare program to provide rebates with respect to amounts of such drugs discarded, and for other purposes.

Introduced: August 9, 2019 See on congress.gov
Health Accounting and auditingCivil actions and liabilityGovernment trust fundsHealth care costs and insurance
More subjectsShow fewer subjects
Health information and medical recordsInflation and pricesMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 12, 2019
Referred to the Subcommittee on Health.
Aug 9, 2019
Referred to the Subcommittee on Health.
Aug 9, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Aug 9, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action August 12, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019

This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties.

The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)

 Related & companion bills 1
  • S 551 Identical bill REFUND Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4178: REFUND Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4178/
MLA
"H.R. 4178: REFUND Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4178/.
Bluebook (legal)
H.R. 4178, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4178/.
Markdown link
[H.R. 4178: REFUND Act of 2019](https://openamerica.io/bill/116-HR-4178/)
Report a problem